Results 171 to 180 of about 23,609 (230)

Bone marrow fibrosis (pseudo-myelofibrosis) in human kala-azar [PDF]

, 2000
Rocha Filho Francisco Dário, Ferreira Francisco Valdeci de Almeida, Mendes Flávia de Oliveira, Ferreira Fernanda Nogueira Holanda, Karbage Alexandre, Alencar Marília Lage, Costa Danielle   +6 more
openalex  

Periportal extramedullary hematopoiesis in a patient with primary myelofibrosis: A great mimicker of an infiltrating tumor in the liver. [PDF]

Radiol Case Rep
Crawford CK, Arshad H, Kawamoto S, Fishman EK.   +3 more
europepmc   +1 more source

Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis. [PDF]

Cancer Immunol Immunother
Villar S, Curis E, Schlageter MH, Bosselut N, Charbonnier A, Rubio MT, Turlure P, Labussière H, Bay JO, Cornillon J, Vincent L, Orvain C, Kiladjian JJ, Michonneau D, Socié G, Robin M.   +15 more
europepmc   +1 more source

Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia

, 2001
Ayalew Tefferi, Michelle A. Elliott, Soo‐Young Yoon, Chin‐Yang Li, Ruben A. Mesa, Timothy G. Call, Angela Dispenzieri   +6 more
openalex   +1 more source

CalR and MPL Driver Mutations and Their Role in the Diagnosis and Clinical Course of JAK2-Unmutated Chronic Myeloproliferative Neoplasm: Results from a Pilot Single-Center Study. [PDF]

Medicina (Kaunas)
Tiryaki TO, Dağlar Aday A, Nalçacı M, Yavuz AS.   +3 more
europepmc   +1 more source

4. Myelofibrosis

Nihon Naika Gakkai Zasshi, 2007
openaire   +3 more sources

Momelotinib in JAK2 inhibitor-naïve myelofibrosis: pros and cons. [PDF]

Blood Cancer J
Gangat N, Tefferi A.
europepmc   +1 more source

Bone Marrow Involment and Myelofibrosis in Hudgkin's Disase

, 1998
Sare Kabukçuoğlu, Ülkü Öner, Zeki Üstüner, Serap Işıksoy, Emine Dündar, Nilüfer Tel   +5 more
openalex  

DNA methylation in primary myelofibrosis is partly associated with driver mutations and distinct from other myeloid malignancies. [PDF]

Clin Epigenetics
Dursun Torlak E, Tharmapalan V, Kricheldorf K, Schifflers J, Caduc M, Zenke M, Koschmieder S, Wagner W.   +7 more
europepmc   +1 more source

Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1. [PDF]

Sci Rep
Naumann N, Dangelo V, Lübke J, Bresser J, Hagen V, Dengler J, Metzgeroth G, Kreil S, Hockenberger T, Hofmann WK, Fabarius A, Saussele S, Cross NCP, Reiter A, Schwaab J.   +14 more
europepmc   +1 more source